PDF(Pubmed)
Abstract：
BACKGROUND: We aimed to evaluate the validity and reliability of the Turkish version of the Patient-Reported Impact of Spasticity Measure (PRISM-TR).
METHODS: Expert opinions and the forward-back translation method were used for linguistic validation. Cronbach α and test-retest analysis were performed for reliability analysis. Correlations between the PRISM-TR and the Modified Ashworth Scale (MAS), the Numerical Rating Scale (NRS), and the Expanded Disability Status Scale (EDSS) were assessed.
RESULTS: A total of 206 individuals with multiple sclerosis (MS; 139 women; mean age, 47.7 ± 11.3 years; mean EDSS score, 5.2 ± 1.5) who had not had a relapse in the previous 3 months were included in the study. Test-retest correlation coefficients were high for all subdimensions of the scale (0.95-0.99). All Cronbach α values for the PRISM-TR subdimensions, except for Positive Impact, were likewise quite high (0.85-0.94). PRISM-TR subscale scores were correlated with MAS, NRS, and EDSS scores (P < .001).
CONCLUSIONS: PRISM-TR is a valid and reliable scale for use with Turkish individuals with MS. It is simple to use in the clinic and can be helpful in detecting patients\' spasticity early in the disease course.
METHODS: Expert opinions and the forward-back translation method were used for linguistic validation. Cronbach α and test-retest analysis were performed for reliability analysis. Correlations between the PRISM-TR and the Modified Ashworth Scale (MAS), the Numerical Rating Scale (NRS), and the Expanded Disability Status Scale (EDSS) were assessed.
RESULTS: A total of 206 individuals with multiple sclerosis (MS; 139 women; mean age, 47.7 ± 11.3 years; mean EDSS score, 5.2 ± 1.5) who had not had a relapse in the previous 3 months were included in the study. Test-retest correlation coefficients were high for all subdimensions of the scale (0.95-0.99). All Cronbach α values for the PRISM-TR subdimensions, except for Positive Impact, were likewise quite high (0.85-0.94). PRISM-TR subscale scores were correlated with MAS, NRS, and EDSS scores (P < .001).
CONCLUSIONS: PRISM-TR is a valid and reliable scale for use with Turkish individuals with MS. It is simple to use in the clinic and can be helpful in detecting patients\' spasticity early in the disease course.
摘要：
背景：我们旨在评估土耳其语版本的患者报告的痉挛影响测量（PRISM-TR）的有效性和可靠性。
方法：使用专家意见和前后翻译方法进行语言验证。进行了Cronbachα和重测分析，以进行可靠性分析。PRISM-TR与改良阿什沃思量表(MAS)的相关性，数值评级量表(NRS)，并评估了扩展的残疾状况量表（EDSS）。
结果：共有206名多发性硬化症患者（MS；139名女性；平均年龄，47.7±11.3年；平均EDSS评分，在前3个月没有复发的5.2±1.5）纳入研究。对于量表的所有子维度，重测相关系数都很高（0.95-0.99）。PRISM-TR子尺寸的所有Cronbachα值，除了积极的影响，同样很高（0.85-0.94）。PRISM-TR分量表评分与MAS相关，NRS,和EDSS评分(P<.001)。
结论：PRISM-TR是一种有效且可靠的量表，适用于患有MS的土耳其人。它在临床上使用简单，有助于在病程早期检测患者的痉挛状态。
方法：使用专家意见和前后翻译方法进行语言验证。进行了Cronbachα和重测分析，以进行可靠性分析。PRISM-TR与改良阿什沃思量表(MAS)的相关性，数值评级量表(NRS)，并评估了扩展的残疾状况量表（EDSS）。
结果：共有206名多发性硬化症患者（MS；139名女性；平均年龄，47.7±11.3年；平均EDSS评分，在前3个月没有复发的5.2±1.5）纳入研究。对于量表的所有子维度，重测相关系数都很高（0.95-0.99）。PRISM-TR子尺寸的所有Cronbachα值，除了积极的影响，同样很高（0.85-0.94）。PRISM-TR分量表评分与MAS相关，NRS,和EDSS评分(P<.001)。
结论：PRISM-TR是一种有效且可靠的量表，适用于患有MS的土耳其人。它在临床上使用简单，有助于在病程早期检测患者的痉挛状态。
